Amy Yamamoto

Amy Yamamoto has experience working as a Director of Clinical Pharmacology at Heron Therapeutics, Inc. since 2017. Prior to that, they worked at Ardea Biosciences as a Scientist in Pharmacokinetics from October 2014 to January 2017, and as an Associate Scientist in Bioanalytical from July 2011 to October 2014.

Amy Yamamoto has a Bachelor of Science (B.S.) degree in Human Biology from UC San Diego, with a minor in Japanese Studies.